Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

HLX10-005-SCLC301-E

Trial Overview

Official Title

HLX10-005-SCLC301-E: A Randomized, Open-label Study of HLX10 plus Chemotherapy (CarboplatinEtoposide) in comparison with Atezolizumab plus Chemotherapy in Previously Untreated US Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) ASTRIDE

Study Purpose

To take part in a clinical research study of an investigational new drug to treat extensive stage small cell lung cancer (ES-SCLC).  To see if HLX10 plus chemotherapy versus atezolizumab plus chemotherapy is efficacious 

Diagnosis

Extensive Stage-=Small Cell Lung Cancer (ES-SCLC)

Eligibility

No prior systemic therapy for ES-SCLC

One measurable lesion

No other active malignancies within 5 years or at the same time

 

Intervention

HLX10 plus chemotherapy versus atezolizumab plus chemotherapy

For more information, visit  Clinicaltrials.gov

Key Participation Requirements
Trial Location(s)
Methodist Estabrook Cancer Center
Gender
Male or Female
Enrollment Status
Recruiting
Phase
Phase III